ST. PAUL, Minn.--(BUSINESS WIRE)--Nov. 2, 2005--MEDTOX Scientific, Inc. (AMEX:TOX), announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Sure-Screen(R) drugs-of-abuse point-of-collection test (POCT) device.